Both in Pharmaceuticals
Xilio Therapeutics vs Rafael Holdings
Over the past year XLO returned −27.1% and RFL returned −20.0%; their daily moves had a correlation of -0.11.
XLO −27.1% RFL −20.0%Growth of $1, one year, split-adjusted
| Metric | XLO | RFL |
|---|---|---|
| Price | $8.68 | $1.08 |
| Market cap | $57.1M | $56.4M |
| Today | +8.64% | +8.00% |
| 1 month | −4.7% | −26.5% |
| 6 months | +12.6% | −15.0% |
| Year to date | −3.2% | −8.5% |
| 1 year | −22.2% | −20.6% |
| Revenue growth (YoY) | +131.2% | −30.3% |
| Gross margin | 100.0% | 94.7% |
| Net margin | −34.1% | −3760.7% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 64.5× |
| Net cash | $136.0M | $21.5M |
| Dividend yield | — | — |
| Volatility (60d) | 38.3% | 115.1% |
| Short % of float | 10.1% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).